194 related articles for article (PubMed ID: 12628332)
21. In vitro transdermal iontophoretic delivery of penbutolol sulfate.
Ita KB; Banga AK
Drug Deliv; 2009 Jan; 16(1):11-4. PubMed ID: 19555303
[TBL] [Abstract][Full Text] [Related]
22. Transdermal iontophoresis of rotigotine across human stratum corneum in vitro: influence of pH and NaCl concentration.
Nugroho AK; Li GL; Danhof M; Bouwstra JA
Pharm Res; 2004 May; 21(5):844-50. PubMed ID: 15180344
[TBL] [Abstract][Full Text] [Related]
23. Skin electroporation for transdermal drug delivery: the influence of the order of different square wave electric pulses.
Zorec B; Becker S; Reberšek M; Miklavčič D; Pavšelj N
Int J Pharm; 2013 Nov; 457(1):214-23. PubMed ID: 24076397
[TBL] [Abstract][Full Text] [Related]
24. [Transdermal properties of timolol and factors affecting its permeability in vitro].
Xu YZ; Xu HN
Yao Xue Xue Bao; 1992; 27(6):467-71. PubMed ID: 1442076
[TBL] [Abstract][Full Text] [Related]
25. Transdermal delivery of fentanyl by electroporation. II. Mechanisms involved in drug transport.
Vanbever R; Morre ND; Préat V
Pharm Res; 1996 Sep; 13(9):1360-6. PubMed ID: 8893275
[TBL] [Abstract][Full Text] [Related]
26. Electronically facilitated transdermal delivery of human parathyroid hormone (1-34).
Medi BM; Singh J
Int J Pharm; 2003 Sep; 263(1-2):25-33. PubMed ID: 12954177
[TBL] [Abstract][Full Text] [Related]
27. Skin electroporation causes molecular transport across the stratum corneum through localized transport regions.
Chen T; Langer R; Weaver JC
J Investig Dermatol Symp Proc; 1998 Aug; 3(2):159-65. PubMed ID: 9734832
[TBL] [Abstract][Full Text] [Related]
28. Transdermal delivery of cyclosporin-A using electroporation.
Wang S; Kara M; Krishnan TR
J Control Release; 1998 Jan; 50(1-3):61-70. PubMed ID: 9685873
[TBL] [Abstract][Full Text] [Related]
29. Electrically enhanced transdermal delivery of a macromolecule.
Badkar AV; Banga AK
J Pharm Pharmacol; 2002 Jul; 54(7):907-12. PubMed ID: 12162708
[TBL] [Abstract][Full Text] [Related]
30. Transdermal iontophoresis of sodium nonivamide acetate. V. Combined effect of physical enhancement methods.
Fang JY; Hwang TL; Huang YB; Tsai YH
Int J Pharm; 2002 Mar; 235(1-2):95-105. PubMed ID: 11879744
[TBL] [Abstract][Full Text] [Related]
31. The effects of iontophoresis and electroporation on transdermal delivery of buprenorphine from solutions and hydrogels.
Fang JY; Sung KC; Wang JJ; Chu CC; Chen KT
J Pharm Pharmacol; 2002 Oct; 54(10):1329-37. PubMed ID: 12396293
[TBL] [Abstract][Full Text] [Related]
32. Transdermal iontophoresis of 5-fluorouracil combined with electroporation and laser treatment.
Fang JY; Hung CF; Fang YP; Chan TF
Int J Pharm; 2004 Feb; 270(1-2):241-9. PubMed ID: 14726139
[TBL] [Abstract][Full Text] [Related]
33. Transdermal delivery of heparin by skin electroporation.
Prausnitz MR; Edelman ER; Gimm JA; Langer R; Weaver JC
Biotechnology (N Y); 1995 Nov; 13(11):1205-9. PubMed ID: 9636293
[TBL] [Abstract][Full Text] [Related]
34. Relationship between amount of beta-blockers permeating through the stratum corneum and skin irritation after application of beta-blocker adhesive patches to guinea pig skin.
Kobayashi I; Hosaka K; Ueno T; Maruo H; Kamiyama M; Konno C; Gemba M
Biol Pharm Bull; 1997 Apr; 20(4):421-7. PubMed ID: 9145222
[TBL] [Abstract][Full Text] [Related]
35. [Transdermal administration of drugs by electroporation].
Vanbever R
Bull Mem Acad R Med Belg; 1999; 154(6 Pt 2):327-33. PubMed ID: 10992881
[TBL] [Abstract][Full Text] [Related]
36. Transdermal permeation of alniditan by iontophoresis: in vitro optimization and human pharmacokinetic data.
Jadoul A; Mesens J; Caers W; de Beukelaar F; Crabbé R; Préat V
Pharm Res; 1996 Sep; 13(9):1348-53. PubMed ID: 8893273
[TBL] [Abstract][Full Text] [Related]
37. Water-activated, pH-controlled patch in transdermal administration of timolol. II. Drug absorption and skin irritation.
Sutinen R; Paronen P; Saano V; Urtti A
Eur J Pharm Sci; 2000 Jul; 11(1):25-31. PubMed ID: 10913750
[TBL] [Abstract][Full Text] [Related]
38. Creation of transdermal pathways for macromolecule transport by skin electroporation and a low toxicity, pathway-enlarging molecule.
Zewert TE; Pliquett UF; Vanbever R; Langer R; Weaver JC
Bioelectrochem Bioenerg; 1999 Oct; 49(1):11-20. PubMed ID: 10619443
[TBL] [Abstract][Full Text] [Related]
39. [The bioavailability of transdermal therapeutic system of timolol].
Ji XF; Ping QN; Liu GJ; Yu ST
Yao Xue Xue Bao; 1993; 28(8):609-13. PubMed ID: 8285070
[TBL] [Abstract][Full Text] [Related]
40. Compartmental modeling of transdermal iontophoretic transport: I. In vitro model derivation and application.
Nugroho AK; Della Pasqua O; Danhof M; Bouwstra JA
Pharm Res; 2004 Nov; 21(11):1974-84. PubMed ID: 15587918
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
